Relief Therapeutics Holding AG (RLFTY)
USD 5.0
(0.0%)
USD 5.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.03 Million | 6.08 Million | 3.32 Million | - | - | 565 Thousand |
| Cost of Revenue | 1.73 Million | 13.64 Million | 19.77 Million | 13.67 Million | 68 Thousand | 55 Thousand |
| Gross Profit | 4.29 Million | -7.56 Million | -16.45 Million | -13.67 Million | -68 Thousand | 510 Thousand |
| Operating Expenses | 114.94 Million | 29.22 Million | 18.81 Million | 6.82 Million | 743 Thousand | 1.01 Million |
| Selling, General and Administrative Expenses | 19.42 Million | 11.05 Million | 7.11 Million | 2.99 Million | 548 Thousand | 514 Thousand |
| Research and Development Expenses | 1.32 Million | 12.39 Million | 19.02 Million | 13.64 Million | - | - |
| Other Expenses | 4.3 Million | 9.07 Million | 19 Thousand | 8000.00 | -51 Thousand | 2000.00 |
| Cost and Expenses | 116.86 Million | 42.86 Million | 38.58 Million | 20.49 Million | 811 Thousand | 1.06 Million |
| Operating Income | -110.82 Million | -52.04 Million | -34.3 Million | -9.08 Million | -12.06 Million | 500 Thousand |
| Interest Expense | - | 156 Thousand | 194 Thousand | 100 Thousand | 134 Thousand | 140 Thousand |
| Income Tax Expense | -13.5 Million | -3.52 Million | -820 Thousand | 1.56 Million | -4.7 Million | 20 Thousand |
| Earnings before Tax | -111.68 Million | -54.31 Million | -35.52 Million | -6.26 Million | -12.16 Million | -416 Thousand |
| Net Income | -98.18 Million | -50.79 Million | -34.7 Million | -7.82 Million | -7.46 Million | -436 Thousand |
| Earnings Per Share Basic | -8.35 | -4.80 | -3.86 | -1.30 | -1.42 | -0.09 |
| Earnings Per Share Diluted | -8.35 | -4.80 | -3.86 | -1.30 | -1.42 | -0.09 |
| Weighted Average Shares Outstanding | 11.75 Million | 10.57 Million | 8.98 Million | 6.03 Million | 5.25 Million | 5.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.75 Million | 10.57 Million | 8.98 Million | 6.03 Million | 5.25 Million | 5.12 Million |
| Gross Margin | 0.71 | -1.24 | -4.95 | - | - | 0.90 |
| EBIT Margin | -17.91 | -4.05 | -10.11 | - | - | -0.46 |
| Profit Margin | -16.27 | -8.35 | -10.45 | - | - | -0.77 |
| EBITDA | -108.03 Million | -49.02 Million | -32.69 Million | -19.36 Million | -827 Thousand | -259 Thousand |
| Earnings Before Tax Margin | -18.37 | -8.56 | -10.33 | - | - | 0.88 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.82 Million | 2.82 Million | 3.01 Million | 6.03 Million | 1.5 Million | 3.02 Million |
| Cost of Revenue | 781 Thousand | 781 Thousand | 8.15 Million | 16.89 Million | 525.5 Thousand | 8.74 Million |
| Gross Profit | 2.04 Million | 2.04 Million | -5.14 Million | -10.85 Million | 979.5 Thousand | -5.71 Million |
| Operating Expenses | 4.03 Million | 4.03 Million | 3.11 Million | 9.04 Million | 24.79 Million | 5.92 Million |
| Selling, General and Administrative Expenses | 2.94 Million | 2.94 Million | 2.62 Million | - | 4.13 Million | 4.9 Million |
| Research and Development Expenses | 366.5 Thousand | 366.5 Thousand | 395 Thousand | - | 20.27 Million | 933 Thousand |
| Other Expenses | 719 Thousand | 719 Thousand | -94 Thousand | -184 Thousand | - | -90 Thousand |
| Cost and Expenses | 4.81 Million | 4.81 Million | 11.26 Million | 25.93 Million | 25.31 Million | 14.66 Million |
| Operating Income | -1.98 Million | -1.98 Million | -8.25 Million | -19.9 Million | -4.12 Million | -11.64 Million |
| Interest Expense | 41 Thousand | - | - | 330 Thousand | - | 89 Thousand |
| Income Tax Expense | 280 Thousand | 280 Thousand | -5.86 Million | -13.5 Million | 2.93 Million | -7.64 Million |
| Earnings before Tax | -1.99 Million | -1.99 Million | -47.54 Million | -111.68 Million | -23.77 Million | -64.14 Million |
| Net Income | -2.27 Million | -2.27 Million | -41.68 Million | -98.18 Million | -20.84 Million | -56.49 Million |
| Earnings Per Share Basic | -0.18 | -0.18 | -3.32 | - | -1.68 | -5.10 |
| Earnings Per Share Diluted | -0.18 | -0.18 | -3.32 | - | -1.68 | -5.10 |
| Weighted Average Shares Outstanding | 12.55 Million | 12.55 Million | 12.54 Million | 11.75 Million | 12.42 Million | 11.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.55 Million | 12.55 Million | 12.54 Million | 11.75 Million | 12.42 Million | 11.08 Million |
| Gross Margin | 0.72 | 0.72 | -1.71 | -1.80 | 0.65 | -1.89 |
| EBIT Margin | -0.45 | -0.45 | -2.21 | - | -2.31 | -3.29 |
| Profit Margin | -0.81 | -0.81 | -13.85 | -16.27 | -13.85 | -18.69 |
| EBITDA | -1.27 Million | -1.27 Million | -6.64 Million | - | -3.47 Million | -9.94 Million |
| Earnings Before Tax Margin | -0.70 | -0.70 | -2.74 | -3.30 | -2.74 | -3.85 |
TOTL
205A
030200
EX9
EVD
0322